A government report reveals that over 100 pharma units' cough syrup samples failed quality tests, showing the same toxins linked to child deaths in Gambia, Uzbekistan, and Cameroon. The Central Drugs Standard Control Organisation's analysis found 353 out of 7,087 batches sub-standard,. Issues include unsecured supply chains and inadequate testing.
